TCTR20210217002招募中4 期
Effect of quercetin supplementation on serum uric acid in obese male patients
/A0 个研究点目标入组 48 人开始时间: 2021年2月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 Years 至 60 Years（—）
- 性别
- Male
入选标准
- •1. male 2. age between 25-60 years 3. BMI > 25 kg/m2 4. serum uric more than 5 mg/dl 5. no Hx of gout and urinary stone 6. no Hx cardiovascular disease 7. no Hx of cancer 8. GFR > 60 ml/min/1.73 m2 9. normal liver function 10. not take any supplement before 2 weeks 11. not take medicine that effect serum uric acid level - Diuretic Aspirin Pyrazinamide Ethambutol Levodopa Cyclosporine Nicotinic acid Sodamint
排除标准
- •1. take lowering uric acid drug between study 2. poor compliance - stop taking supplement more than 2 days 3. severe adverse effect 4. got serious health problem
研究者
相似试验
已完成
3 期
Effect of quercetin in treatment of strokecerebral infarction( ischemic stroke).Cerebral infarctionIRCT201202269142N1Tehran University of Medical Sciences72
已完成
3 期
Effect of Quercetin supplementation on inflammatory and Creatinine kinase responses after a swimming session in girlsIRCT20200804048307N1Islamic Azad University20
已完成
2 期
Quercetin in thalassemiabeta thalassemia major.Cooley anaemia Severe beta thalassaemia Thalassaemia: intermedia majorIRCT201701172709N43Vice chancellor for research, Iran University of Medical Sciences84
已完成
不适用
Effect of co-administration of quercetin on the endothelial dysfunction after continuous treatment of nitroglycerin in Japanese volunteers with aldehyde dehydrogenase2 *2 polymorphism: randomized crossover trialangina pectorisJPRN-UMIN000033639SOUSEIKAI Fukuoka Mirai Hospital, Clinical Research Center24
已完成
3 期
Quercetin in COVID19COVID19.Corona virus infection, unspecifiedU07.1IRCT20200419047128N2Ahvaz University of Medical Sciences60